Feed IVVD
IV

Invivyd, Inc.

IVVD · NASDAQ

$0.76 -1.15% (-$0.01)
1M -19.86%
Market Cap $222.5M
P/E Ratio -
Div. Yield -
ROE 59.73%
Piotroski F-Score Weak
1/9
Valuation
73 /100
Cheap
P/S 3.81x
P/B 1.23x
P/E N/A
Growth
0 /100
Declining
Book val. growth 12.13%
EPS growth N/A
Rev. growth N/A
Profitability
20 /100
Weak
Gross margin 91.35%
Net margin 183.90%
Op. margin 192.81%
Quality
3 /100
Poor
ROIC 59.39%
ROE 59.73%
ROA 49.04%
Debt
100 /100
Low
Debt/Equity 0.05x
Current ratio 5.87x
Int. coverage N/A
Stability
62 /100
Moderate
Beta 0.71x
EPS volatility 34.84%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about IVVD
Online

About the company

Invivyd, Inc. (IVD) is an American company specializing in the development and provision of innovative solutions in the field of digital healthcare. With a product portfolio that includes health technologies, telemedicine, and digital diagnostics, Invivyd, Inc. is a key player in the transformation of the healthcare sector. The company focuses on providing efficient and affordable digital tools for monitoring and improving healthcare. Invivyd, Inc. (IVD) also keeps a close eye on emerging trends in e-health and consistently invests in research and development. Shares of Invivyd, Inc. (IVD) could be suitable for investors looking to invest in digital healthcare with an emphasis on innovation and enhancing patient care.

Sector

Healthcare

Industry

Biotechnology

CEO

Marc William Elia

Employees

122

Headquarters

New Haven

Upcoming events

05 NOV

Earnings

Upcoming earnings report

45d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.